Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Cash & Equivalents: 2015-2024

Historic Cash & Equivalents for Zepp Health (ZEPP) over the last 10 years, with Dec 2024 value amounting to $91.1 million.

  • Zepp Health's Cash & Equivalents fell 45.94% to $61.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 billion, marking a year-over-year decrease of 45.94%. This contributed to the annual value of $91.1 million for FY2024, which is 31.87% down from last year.
  • Per Zepp Health's latest filing, its Revenue - Interest and Investment Income stood at $596.7 million for FY2023, which was up 0.63% from $593.0 million recorded in FY2022.
  • In the past 5 years, Zepp Health's Cash & Equivalents ranged from a high of $348.4 million in FY2020 and a low of $91.1 million during FY2024.
  • For the 3-year period, Zepp Health's Revenue - Interest and Investment Income averaged around $397.2 million, with its median value being $593.0 million (2022).
  • Data for Zepp Health's Revenue - Interest and Investment Income shows a peak YoY soared of 31,108.95% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Zepp Health's Cash & Equivalents stood at $348.4 million in 2020, then crashed by 33.86% to $230.4 million in 2021, then tumbled by 44.22% to $128.6 million in 2022, then rose by 3.98% to $133.7 million in 2023, then slumped by 31.87% to $91.1 million in 2024.